Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
MDGL Key Statistics
Stock Snapshot
The current Madrigal Pharmaceuticals(MDGL) stock price is $601.03, with a market capitalization of 13.64B. The stock trades at a price-to-earnings (P/E) ratio of -45.51.
During the trading session on 2025-11-26, Madrigal Pharmaceuticals(MDGL) shares reached a daily high of $604.59 and a low of $585.09. At a current price of $601.03, the stock is +2.7% higher than the low and still -0.6% under the high.
Trading volume for Madrigal Pharmaceuticals(MDGL) stock has reached 246.98K, versus its average volume of 403.42K.
The stock's 52-week range extends from a low of $265.00 to a high of $604.59.
The stock's 52-week range extends from a low of $265.00 to a high of $604.59.
MDGL News
Madrigal Pharmaceuticals (MDGL) is drawing interest after sharing two-year results from its Phase 3 MAESTRO-NAFLD-1 trial at a major liver disease conference. T...
New insider activity at Madrigal Pharmaceuticals ( (MDGL) ) has taken place on November 21, 2025. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for...
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Madrigal Pharmaceuticals, with a price target of $620.00. TipRanks Black...